Substance P Activates Mast Cell Receptor MRGPRX2 Through Both G-Protein and Arrestin Pathways | Research

The takeaway

Substance P acts as a balanced agonist at MRGPRX2, activating both G-protein and β-arrestin signaling, with a single tyrosine residue (Tyr279) essential for both pathways.

Single residue controls dual signaling
Tyr279 in MRGPRX2's NPxxY motif is essential for both G-protein and β-arrestin-mediated responses to substance P

What the researchers found

Substance P serves as a balanced agonist for MRGPRX2, activating both G-protein and β-arrestin pathways. Tyr279 in the NPxxY motif is essential for both signaling modes.

Why it matters

MRGPRX2 is a key mediator of drug-induced pseudo-allergic reactions, neurogenic inflammation, and itch. Understanding how substance P activates this receptor could lead to better treatments for inflammatory skin conditions and drug reactions.

The numbers in context

2 pathways: G protein + beta-arrestin; Y279A blocks beta-arrestin and internalization; balanced agonism by SP

How the study worked

Cell-based assays measuring G-protein signaling, β-arrestin recruitment, MRGPRX2 internalization, and desensitization. Site-directed mutagenesis (Y279A). G-protein independence verified with G-protein inhibitors.

Who was studied

MRGPRX2-expressing cells with wild-type and Y279A mutant receptor

What this study cannot tell us

Cell-based overexpression system may not fully reflect native receptor behavior. Focused on one agonist (substance P); other MRGPRX2 agonists may have different signaling profiles.

How to read the evidence

Rigorous in vitro mechanistic study with mutagenesis validation. Strong molecular pharmacology evidence.

When this study was published

Published in 2021, advancing understanding of MRGPRX2 pharmacology and substance P signaling.

The bigger picture

MRGPRX2 has emerged as a major target for drug-induced pseudo-allergic reactions and neurogenic inflammation. Understanding that substance P causes both activation and self-limiting desensitization through balanced agonism provides insights for developing better anti-inflammatory strategies.

Questions still open

Could biased MRGPRX2 agonists or antagonists be developed for specific therapeutic effects?
Is the β-arrestin pathway protective or pathological in neurogenic inflammation?
Do other neuropeptide MRGPRX2 agonists show similar balanced agonism?

Common questions

What is MRGPRX2 and why does it matter?

MRGPRX2 is a receptor on mast cells that responds to various molecules including neuropeptides and certain drugs. When activated, it causes mast cells to release inflammatory chemicals. It's responsible for many drug-induced pseudo-allergic reactions and contributes to inflammatory skin conditions like eczema.

What does 'balanced agonist' mean?

It means substance P activates two different signaling pathways through MRGPRX2 equally. One pathway (G-protein) triggers mast cell activation, while the other (β-arrestin) leads to the receptor being pulled inside the cell, effectively shutting it down. This built-in on/off mechanism helps regulate the inflammatory response.

Read the original research

Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.

International journal of molecular sciences, 22(10)

View on PubMed ↗Publisher’s paper ↗

Citation

Chompunud Na Ayudhya, Chalatip; Amponnawarat, Aetas; Ali, Hydar. (2021). Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization.. International journal of molecular sciences, 22(10). https://doi.org/10.3390/ijms22105318